Quarterly report pursuant to Section 13 or 15(d)

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Major Vendor (Details)

v3.23.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Major Vendor (Details) - Supplier Concentration Risk - Vendor One
3 Months Ended 12 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Research and development expenditures      
Concentration      
Concentration Risk (as a percent) 60.00% 49.00%  
Accounts payable and accrued expense      
Concentration      
Concentration Risk (as a percent) 82.00%   56.00%